Snowball logo
logo
CRDL

Cardiol Therapeutics Inc Class A

$1.06+$0.05Β  (4.95%)

Frequently asked questions

What sector does Cardiol Therapeutics Inc Class A (CRDL) operate in?

Cardiol Therapeutics Inc Class A belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Cardiol Therapeutics Inc Class A (CRDL) current stock price?

As of the latest data, Cardiol Therapeutics Inc Class A stock price is $1.06, with a previous close of $1.01. Cardiol Therapeutics Inc Class A gained $0.05 in the last trading session, representing a 4.95% increase.

What is Cardiol Therapeutics Inc Class A (CRDL) current market capitalization?

Cardiol Therapeutics Inc Class A market cap is approximately 122.19 million.

What is Cardiol Therapeutics Inc Class A (CRDL) Earnings Per Share (EPS)?

The trailing EPS is -$0.27, and the forward EPS is -$0.28.

What is Cardiol Therapeutics Inc Class A (CRDL) EBITDA?

Cardiol Therapeutics Inc Class A EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -7.78 million.

Does Cardiol Therapeutics Inc Class A (CRDL) pay dividends?

No. Cardiol Therapeutics Inc Class A does not pay a dividend.

When is Cardiol Therapeutics Inc Class A (CRDL) next earnings report?

Cardiol Therapeutics Inc Class A is expected to release its next earnings report on June 30, 2026.

What is Cardiol Therapeutics Inc Class A (CRDL) beta (volatility) score?

Cardiol Therapeutics Inc Class A has a beta of 0.481, indicating lower volatility than the overall market.